Systematic disease-agnostic identification of therapeutically actionable targets using the genetics of human plasma proteins
Mohd Anisul Karim(Wellcome Sanger Institute), Maya Ghoussaini(Regeneron (United States)), Edward Mountjoy(Open Targets), Chloe Robins(Institut thématique Génétique, génomique et bioinformatique), James Hayhurst(European Bioinformatics Institute), Miguel Carmona(European Bioinformatics Institute), Bruno Ariano(Wellcome Sanger Institute), Andrew R. Leach(LifeArc), Jeremy Schwartzentruber(McGill University and Génome Québec Innovation Centre), Juan María Roldán‐Romero(European Bioinformatics Institute), Ellen M. McDonagh(Wellcome Sanger Institute), Michael V. Holmes(University of Oxford), Annalisa Buniello(European Bioinformatics Institute), Elmutaz Shaikho Elhaj Mohammed(Bristol-Myers Squibb (Germany)), David Ochoa(European Bioinformatics Institute), Joseph Maranville(Finnish Institute for Health and Welfare), Praveen Surendran(University of Cambridge), Robert A. Scott(Age UK), Stephen A. Haddad(GlaxoSmithKline (United States)), Ian Dunham(Wellcome Sanger Institute)
Cited by 7
Related Papers
Initial sequencing and analysis of the human genome
|Nature|2001|24.6k
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
|Journal of Molecular Biology|1997|6.7k
ChEMBL: towards direct deposition of bioassay data
|Nucleic Acids Research|2018|2.5k
The ChEMBL database in 2017
|Nucleic Acids Research|2016|2.4k
Molecular Modelling: Principles and Applications
|Unknown|1996|1.9k